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ABSTRACT  
Contraceptives are intentional prevention of conception through the use of various devices sexual practices, chemicals, drugs or surgical 
procedures become a contraceptive if its purpose is to prevent a woman from becoming pregnant. This is a cross sectional study conducted at 
ALnow Hospital Khartoum, Sudan,  the study aimed to estimate D.dimer levels among Sudanese women take contraceptive pill.    50 Women 
uses contraceptive pill used as a cases and 50 apparently health women were used as a control. Three   ml of venous blood samples were 
collected from each subject in 3.8% tri-sodium citrate (9:1 vol/vol) for D-dimer analysis.  The study revealed that was clearly significant 
increase in D.dimer in women take oral contraceptive pill (p.value 0.000), also the study concluded that D-dimer level was increased in users 
oral contraceptive Sudanese women,  that is increase the coagubility of the blood  and might be become as a risk factor.    
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INTRODUCTION     
Contraceptives are intentional prevention of conception 
through the use of various devices sexual practices, 
chemicals, drugs or surgical procedures become a 
contraceptive if its purpose is to prevent a woman from 
becoming pregnant [1].  
The contraceptives pills are the common name for oral 
contraception, it's one of the safest, most effective and 
popular methods of birth control. The pill is made up of 
synthetic forms of hormones that naturally occur in a 
female's body progesterone and estrogen, it is works by 
stopping the action of the hormones that trigger ovulation 
and preventing the release of an egg; it also thickens the 
cervical mucus, so it makes it hard for sperm to swim. [1] 
There are two kinds of oral contraceptives; combined oral 
contraceptives (COCs), which contain an estrogen and 
progestin. Progestin only contraceptives (POPs), which 
contain a progestin with no estrogen. Combined oral 
contraceptives are obtainable in 2 basic formulations; the 
monophasic formulation; in which each active pill contains 
the same doses of estrogen and progestin, the multiphasic 
formulations; have different amounts of estrogen or 
progestin in the active pills.  
There are multiple different types of combined oral 
contraceptive pill use that  are options; 28-day cycling; most 
pill packs have 21 active hormone pills and 7 inactive 
(placebo) pills. Shortened pill free interval starting the new 
pack of pills on the first day of menstruation usually 
decreases the pill-free interval thus allowing less time for a 
new follicle to develop. Pill-free interval should not be more 
than 7 days. Extended regimens; there is no biological reason 
to have monthly with drawal bleeding on oral contraception. 
There are multiple extended regimens and there are some 
pills that are formulated and packaged specifically for this 
type of extended regimen. If a client chooses an extended 
regimen, a monophasic, combined oral contraceptives must 
be used.[2]  
Advantages and Disadvantages of contraceptives pills:  
Combined oral contraceptives (COCs) benefits; effectiveness, 
safety in years of consecutive use without risk of 
complications, ease of reversibility, positive menstrual 
effects such as; decreased cramps, decreased blood loss and 
reduction of premenstrual symptoms.   
Combined oral contraceptives (COCs) disadvantages; must 
be taken daily, expensive provide no protection against 
sexually transmitted infections including HIV, have Possible 
side effects including; missed periods, breakthrough 
bleeding, nausea, vomiting, headaches depression and 
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decreased libido.  
Progestin-only contraceptive pill (POCs) benefits; estrogen-
free and therefore; useful for clients unable to tolerate the 
estrogen  effects of combined oral contraceptives or who 
have contraindications against  taking an estrogen containing 
contraceptive, can be taken during lactation and appears to 
have no harmful effect on blood pressure or on coagulation. 
Progestin contraceptive POCs) disadvantages pills; only 
irregular menstruation. 
 The combined oral contraceptives  have Serious side effects 
such as; sharp chest pain, coughing up blood, or sudden 
shortness of breath,  pain in calf or leg, crushing chest pain or 
tightness in the chest, sudden severe headache or vomiting, 
dizziness or fainting, disturbances of vision or speech, 
weakness or numbness in an arm or leg, sudden partial or 
complete loss of vision, breast masses suspicious for 
potential malignancy, severe abdominal pain or tenderness, 
severe problems with sleeping, weakness, lack of energy, 
fatigue, or change in mood, Jaundice and swelling of the 
fingers or ankles. Also it has a Possible health risks  such as;  
high blood pressure , thrombophlebitis and venous 
thrombosis with or without embolism arterial 
thromboembolism, pulmonary embolism, myocardial 
infarction, cerebral hemorrhage Cerebral thrombosis, gall 
bladder disease, hepatic adenoma and cigarette smoking 
increases the risk of serious cardiovascular side effects from  
hormonal contraceptive use. [3] 
D- dimer: 
Is a fibrin degradation product (or FDP), a small protein 
fragment present in the blood after a blood clot is degraded 
by fibrinolysis [4]. Values of estimation D-dimer is estimation 
of quantitative D- dimer level has many diagnostic and 
prognostic values such as; diagnosis of venous 
thromboembolism (VTE), identification of individuals at 
increased risk of first thrombotic event (both arterial and 
venous), identification of individuals at increased risk of 
recurrent VTE establishment of the optimal duration of 
secondary prophylaxis after a first episode of VTE pregnancy 
monitoring and  diagnosis monitoring of disseminated 
intravascular coagulation       
Since the 1960s oral contraceptives have been a well-known 
risk factor for thromboembolic episodes. Studies indicate 
that in women taking contraceptives the risk of venous 
thrombosis increases by 3–6 times [5].  The most common 
reason for the discontinuation of contraception by women is 
the occurrence or fear of adverse effects; the most severe 
ones are thromboembolic Complications that may be a direct 
cause of death. The oral contraceptive is most widely uses in 
Sudan, for that is most important to do research in this area 
to increase the awareness of Sudanese women about the 
complication of these contraceptives.  
MATERIALS & METHODS 
This was a cross sectional study,  conducted at the ALnow 
Hospital, Khartoum, Sudan during the period May 2019 to 
July 2019. 50 Sudanese women uses contraceptive pill used 
as a cases and  50 apparently health women were used as a 
control.  The data was collected using pre-designed 
structural questionnaire, the demographic, clinical data and 
the laboratory data included the D-dimer concerning each 
participant were obtained.  The study was approved by the 
ethical committee of the AL now hospital.  Three   ml of 
venous blood were collected  in 3.8% tri-sodium citrate (9:1 
vol/vol) for D-dimer analysis, blood samples were 
centrifuged for 5 minutes at 2500 rpm, then the  plasma was 
separated and stored at -20 °C until analyzed. 
Test procedure  
Firstly Samples were thawed by placing in a water bath for 
15-20 minutes at 37 °C.  10µL of sample was transfer using 
pipette to a tube containing the detection buffer and closed 
the lid of the detection buffer tube, then was mixed the 
sample thoroughly by shaking it about 10 times. (The sample 
mixture must be used immediately.). 75 μL of a sample 
mixture was pipette and dispensed into the sample well on 
the cartridge. Then the sample-loaded cartridge was 
incubated at room temperature for 12 minutes. To scan the 
sample-loaded cartridge, was inserted into the cartridge 
holder of the Instrument for ichroma™ tests (Ensure proper 
orientation of the cartridge before pushing it all the way 
inside the cartridge holder).  The test result was read on the 
display screen of the Instrument for ichroma™ tests. 
RESULTS 
In the present study 50 of contraceptive women were 
included. Equal percentage presented among case population 
that age group less than 30 years and more than 30 years 
(50%) respectively. In addition, 50 of apparently healthy 
women were selected as control group, (82%) their age 
group less than 30 years and (9%) more than 30 years (fig 1) 
(Table 1). 
Other data of the research revealed that; the frequency of the 
woke women among the case group about (28%) most of 
them had not a work (72%) (Table 2) (fig2). Regarding the 
type of contraceptive were used; More than half of them 
(54%) had used (levonogesteral and ethinyle estradiol 
tablets) Familia contraceptive and (46%) had used 
(ethinylestadiol and desogestrel ) Marvelon (table3) (fig3). 
Majority of them used contraceptive for less than 2 years 
(62%) and (38%) were used from 2-7 years (table4) (fig4), 
also about (76%)   had less than three children while few of 
them had more than 3 children (24%) (table5) (fig5). (86%) 
hadn’t a history of abortion, (12%) had one abortion and 
(2%) had two times abortion (table6) (fig6). (96%) hadn’t 
thrombosis, while 4% had thrombosis (table7) (fig7).  For 
the chronic diseases most of them (80%) were normal, 
(10%) had Diabetes mellitus, (8%) had hypertension and 
(2%) had cardiac aorta (table8) (fig8). 
Table (1): Frequency of age group in case and control 
Study 
Population 
Age group 
Less than 30 years More than 30 years 
Case 25(50%) 25(50%) 
Control 41(82%) 9(18%) 
 
 
Fig (1): age group among study population 
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The D-dimer result  
When compared the D- dimer between cases and control 
there was a significant results (P = 0.000) (table 9).  
When the D.dimer correlated with age, types of 
contraceptives, duration of contraceptive numbers of 
deliveries, abortion, thrombosis and other disease among 
case population there was only one  significant result in the 
duration  of contraceptive pill taken (P = 0.000) (table10 ) 
Table (2): Frequency of work women among case 
population 
Work Frequency Percent 
Yes 14 28 
No 36 72 
Total 50 100 
 
 
 
Fig (2): Frequency of work women 
 
Table (3):  Types of contraceptive among case 
population 
Type of Contraceptives Frequency Percent 
Familia 27 54 
Marvelon  23 46 
Total 50 100 
 
 
 
Fig (3): Types of contraceptives 
Table (4): Duration of contraceptive among case 
population 
Duration of contraceptive Frequency Percent 
7month-2 years 31 62 
2-7 years 19 38 
Total 50 100 
 
 
Fig (4): Duration of contraceptive 
 
Table (5): Number of deliveries among case population 
Number of deliveries Frequency Percent 
Less than 3 children 38 76 
More than 3 children 12 24 
Total 50 100 
 
 
Fig (5): Number of deliveries among case population 
 
Table (6): Number of abortions among case population 
Times of Abortion Frequency Percent 
1 6 12 
2 1 2 
No  43 86 
Total 50 100 
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Fig (6): Times of abortion 
Table (7): Thrombosis among case population 
Thrombosis Frequency Percent 
Yes 2 4 
No 48 96 
Total 50 100 
 
 
Fig (7): Thrombosis among case population 
Table (8): Other disease among case population 
Diseases  Frequency Percent 
D.M 5 10 
Hypertension 4 8 
Cardiac Aorta 1 2 
No 40 80 
Total 50 100 
 
 
Fig (8): Other disease among case population 
Table (9): Mean and STD of D. dimer among study 
population 
 Parameters Case 
(mean ±Std) 
Control 
(mean ±Std) 
P. 
value 
D. dimer result 0.35 ± 0.07 0.21± 0.07 0.000 
 
Table (10): comparison of D.dimer with age, type of 
contraceptive, delivery, no of deliveries, abortion, 
duration of contraceptive, thrombosis and other disease 
among case population 
Variables  p.value 
Age  0.52 
Type of contraceptive 0.26 
Delivery 0.24 
number of delivery 0.13 
Abortion 0.31 
Duration 0.000 
Thrombosis 0.78 
Other disease 0.23 
 
DISCUSSION: 
This is across sectional study conducted in women at 
Khartoum state from 1/7/2019 to 10/9/2019 to asses D-
dimer level in contraceptive pill and the result compared 
with normal healthy women as a control. The collected data 
were analyzed by statistical package of social science (SPSS) 
program, this research revealed  the following results; the 
frequency of Age group; in case group 25(50%)   less than 30 
years and 25(50%)   more than 30 years , for control  group; 
41(82%) less than 30 years and 9(18%) more than 30 years. 
Contraceptive pill has been available in pharmacies for more 
than 50 years. Owing to its high effectiveness, full 
reversibility of its effects and high acceptability by women, it 
has become the most universal contraceptive method 
Currently, it is estimated that approx. 100 million women 
take the contraceptive pill [5]. 
 In the present study there was a significant difference in D. 
dimer result in case group (mean 0.35, Std ± 0.07) when 
compared with control group (mean 0.21± , Std 0.07 Std) 
(p.value 0.000)  that is consistent with other study which 
reported; significant positive D-dimer in users women than 
nonusers contraceptives pill [6]. Also Meijers et al said; that 
was a significant increase of D-dimer during the use of the 
pills. [7]  
 In this study the frequency of contraceptive according to 
their types; famila contraceptive (contain two hormones; 
progestin and an estrogen) (Frequency 27) (54%) and 
marvelon contraceptive (contain two hormones; 
progestogen and an estrogen) (Frequency 23) (46%), the 
two types are more popular used in Sudan. when they were 
correlated with D- dimer in the case group there was 
insignificant result with (p ≥ 0.05). One of the studies 
revealed that; there are great differences between individual 
progesterone components used in contraceptives and that 
the final effect of a progesterone component depends on the 
type and dose of the combined oestrogen. It has been shown 
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that oral contraceptives influence the level of almost every 
protein of the blood coagulation system[8]. Also Vliet et al 
showed that; a greater oestrogen level in hormonal 
contraceptives contributes to an increased level of sex 
hormone-binding proteins (SHBPs). The impact of 
contraceptives on the increased level of SHBPs may be a risk 
indicator for a thromboembolic event [9] 
The frequency of contraceptive duration was taken by the 
women;  less than 2 years (Frequency 31) (62%) and 2-7 
years (frequency 19) (38%) . when the D-dimer correlated 
with the duration there was  a significant result (p.value 
0.000),   that is agree with other study which reported;   D-
dimer levels increased gradually during a single cycle of oral 
contraceptive  use at least as much as the increases reported 
after 3 and 6 cycles of oral contraceptive  [10] .  Also Van et al 
said; the risk of venous thrombosis was clearly highest 
during the first three months of use. After one year, the risk 
of venous thrombosis for oral contraceptive compared with 
non-users decreased to the overall estimate of a fivefold 
increased risk [11] .  Another study observed the increase of 
D-dimer level occurring after 3 months of pills use [12] 
In addition to that; the frequency of the number of abortions 
among case population in one abortion (frequency 6) (12%) 
and frequency of two time abortion (frequency 1) (2%) and 
Majority of them hadn’t a history of abortion (frequency 43) 
(86%). Also, the frequency of the thrombosis among case 
population with thrombosis (frequency 2) (4%) the 
reminder frequency without thrombosis (frequency 48) 
(96%). when they were correlated with D- dimer in the case 
group there was insignificant result with (p ≥ 0.05). As 
shown in the available publications, oral contraceptives 
increase the risk of thromboembolic episodes manifesting as 
an ischemic stroke or myocardial infarction, while the main 
factor responsible for the formation of thrombi is the 
oestrogen component level in the pill. Another publications 
have been describing an oestrogen/progesterone complex 
increasing the risk of thrombi and embolisms [13]. Tanis et al 
emphasise the increased risk of arterial thrombosis induced 
by oral contraceptive use is more pronounced in smokers 
and women with hypertension, diabetes or 
hypercholesterolemia [14] . 
Finally; the D- dimer correlated with other diseases (diabetes 
mellitus, hypertention and cardiac aorta) in the case group 
the result was insignificant with (p ≥ 0.05). While the 
frequency of the disease among case group: diabetes mellitus 
10%, hypertension 8% and Cardiac Aorta 2%. The literature 
confirm that the oral contraceptive pills have many side 
effect like; thromboembolic disorders, diabetes mellitus 
complicated by vascular disease severe hypertension and 
valvular heart disease with complications [15]. 
CONCLUSION  
D-dimer level was significantly increased in users oral 
contraceptive sundaes women,  that is increase the 
hypercoagubility of the blood  and might be become as a risk 
factor.    
 Indeed it most important to implement education program 
in Sudan by the family medicine in the hospitals, health 
center and the clinics about the contraceptive to increase the 
women awareness for how to select the suitable type of 
contraceptive according to their health status, the 
effectiveness of contraceptive, the side effect of 
contraceptive and the most important things is a follow up in 
1-3 months for evaluation for oral contraception 
continuation.  
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